Envoy Medical, Inc. - Class A Common Stock (COCH)

COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

COCH stock results show that Envoy Medical beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioVie shares dipped 41.8% to $1.10 in pre-market trading Here are some other stocks moving in pre-market trading.

We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning!

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!